Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease
Status:
WITHDRAWN
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate the efficacy and safety of Volenrelaxin in adults with Chronic Kidney Disease. The study will last about 24 weeks.